Meeting
2019 ASCO Annual Meeting
Hormone replacement therapy (HRT) and risk of distant recurrence in newly diagnosed ER+, node-negative (N-) breast-cancer (BC) patients: A retrospective population-based matched-cohort study.
Authors
Ariel Hammerman
Clalit Health Services Headquarters, Tel-Aviv, Israel
Ariel Hammerman , Ilan Feldhamer , Sari Greenberg-Dotan , Nicky Liebermann , Rinat Yerushalmi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research, Clinical Informatics, and Quality of Care
Track
Quality Care/Health Services Research
Sub Track
Outcomes
Citation
J Clin Oncol 37, 2019 (suppl; abstr 6591)
DOI
10.1200/JCO.2019.37.15_suppl.6591
Abstract #
6591
Poster Bd #
282
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
A novel 95-gene signature (Curebest 95GC Breast) that predicts recurrence-risk in patients with ER-positive, HER2-negative, node-negative, early-stage primary invasive breast cancer with an intermediate Oncotype DX Recurrence Score.
First Author: Takeo Fujii
Poster
2023 ASCO Genitourinary Cancers Symposium
Associations between plant-based diets and risk of disease progression in men with prostate cancer.
First Author: Vivian N Liu
Poster
2022 ASCO Annual Meeting
Variation in recurrence rate and overall survival (OS) outcomes by disease stage and incremental impact of time to recurrence on OS in localized renal cell carcinoma (RCC).
First Author: Naomi B. Haas
Poster
2022 ASCO Annual Meeting
Association of progesterone receptor status with 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer.
First Author: Sung Jun Ma